Webinar | First Scientists To Grow and Share COVID-19 With World

Join AustCham China for a webinar with Professor Sharon Lewin, Director, Peter Doherty Institute for Infection and Immunity to be held Thursday 20 February. The Doherty Institute in Melbourne were the first to grow and share the COVID-19 virus with the world. A eureka moment in the global race to develop a vaccine. 

Tune in to hear Prof. Lewin provide insight on what is currently known about the virus, how is the current situation likely to develop and what has been learned from this outbreak which will influence how the next pandemic will be tackled. 

Prof. Lewin will also be providing details on the Doherty Institute’s success in being the first to grow the COVID-19 from a patient sample and what this means in terms of investigating, diagnosing and treating the virus globally. 

In addition to this presentation, Tim White, Trade Commissioner and Commercial Consul, West China, Australian Trade and Investment Commission, Head of Austrade China’s International Health team, will present a holistic overview of the impacts the COVID-19 virus will have on Australia’s engagement with China in the medical sector.

Event Details：

Date: Thursday 20 February
Time: 11:00AM – 12:00PM China Standard Time
Format: Webinar

Click here to register or scan code below:

Scan the QR code to register

Professor Sharon Lewin

Leading infectious diseases expert, Professor Sharon Lewin, is the inaugural Director of the Doherty Institute. She is also a Professor of Medicine at The University of Melbourne and a National Health and Medical Research Council (NHMRC) Practitioner Fellow. As an infectious diseases physician and basic scientist, her laboratory focuses on basic, translational and clinical research aimed at finding a cure for HIV and understanding the interaction between HIV and hepatitis B virus. Her laboratory is funded by the NHMRC, the National Institutes of Health, The Wellcome Trust, the American Foundation for AIDS Research and multiple commercial partnerships. She is also the Chief Investigator of a NHMRC Centre of Research Excellence (CRE), The Australian Partnership for Preparedness Research on Infectious Diseases Emergencies (APPRISE) that aims to bring together Australia’s leading experts in clinical, laboratory and public health research to address the key components required for a rapid and effective emergency response to infectious diseases.

Tim White

Tim manages the Austrade West China team, with responsibility for advancing Australia’s trade and investment relationships with China’s fastest growing region – a market of 200 million people across Sichuan, Chongqing, Yunnan and Guizhou.Tim also leads Austrade China’s International Health team, working to open new opportunities for Australian business in China’s vast and dynamic healthcare, life sciences and aged care markets. Tim has extensive experience in international business engagement, trade and economic policy development and economic analysis. He has a deep understanding of the Chinese market and the opportunities on offer for Australian business. He has worked closely with a range of Chinese companies investing in Australia. Tim previously served for over ten years with the Department of Foreign Affairs and Trade, including in Beijing, Shanghai and Canberra. He is fluent in Mandarin.